Message #8 From:
NewsBot Date: August 7, 2006 08:16:00 AM
PHLI News Accelerade(R) Powers Lessing to Victory in Vineman Triathlon
MATAWAN, N.J.--(BUSINESS WIRE)--Aug. 7, 2006--PacificHealth Laboratories (OTCBB: PHLI) today announced that Accelerade, the only sports drink with the patented and proven-effective 4:1 carbohydrate to protein ratio, helped power Simon Lessing, one of the leading triathletes in the world, to victory in the 2006 Vineman Ironman 70.3 Triathlon.
The Vineman Ironman 70.3 was held on July 30, 2006. It is one of the most popular and highly competitive triathlons in the world. This year there were 2,000 competitors. Lessing's winning time was almost 1 1/2 minutes faster than that of the second place finisher. One of the top triathlete competitors for the last decade, Lessing is a five-time world champion.
The Vineman win was particularly gratifying for Lessing since he has been hampered by injuries this year. Following his race victory, Lessing said, "As a triathlete, finding better ways to nourish and fuel your body is as important to improvement as finding better ways to train and better equipment to use. Based on Dave Scott's recommendation, I have been using Accelerade and Accel Gel in training and competition. It truly makes a difference in my energy level, performance, and recovery." Six-time Ironman world champion Dave Scott is Lessing's coach.
Dr. Robert Portman, CEO of PacificHealth Laboratories, makers of Accelerade said, "In an event such as an Ironman 70.3, proper nutrition often represents the difference between winning and losing. Accelerade Sports Drink and Accel Gel, which were used by Simon on the course, have shown their superiority in the sports science labs, but it's even more gratifying to see these products helping elite athletes in real-world competition."
PacificHealth Laboratories, Inc. (PHLI.OB), a leading nutrition technology company, has been a pioneer in discovering, developing and commercializing patented, protein-based nutritional products that stimulate specific peptides involved in appetite regulation and that activate biochemical pathways involved in muscle performance and growth. PHLI's principle areas of focus include weight loss, management of Type 2 diabetes and sports performance. To learn more, visit www.pacifichealthlabs.com.
Notice: This news release and oral statements made from time to time by Company representatives concerning the same subject matter may contain so-called "forward-looking statements". These statements can be identified by introductory words such as "expects", "plans", "will", "estimates", "forecasts", "projects" or words of similar meaning and by the fact they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing new products and their potential. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known, such general economic conditions, consumer product acceptance and competitive products, and others of which are not. No forward-looking statements are a guarantee of future results or events, and one should avoid placing undue reliance on such statements.
